BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4294232)

  • 1. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sodium desoxycholate extract according to Barta from Bordetella pertussis as an antigen for the serological antibody demonstration in the complement fixation reaction and in latex slide test].
    Hering H; Mochmann H; Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):149-54. PubMed ID: 4297442
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the soluble fraction of Bordetella pertussis isolated with sodium desoxycholate].
    Soare I; Barber C; Dumitresco M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):839-44. PubMed ID: 4284319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration of Bordetella pertussis antibodies by the latex slide test in comparison to agglutination and complement fixation test].
    Mochmann H; Hering L
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):143-8. PubMed ID: 4297441
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate.
    BARTA G
    J Immunol; 1963 Jan; 90():72-80. PubMed ID: 13969631
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of Bordetella pertussis on rosette-forming cells present in the peritoneal fluids of mice.
    Fishel CW; Pross SH; Klein TW
    J Reticuloendothel Soc; 1976 Feb; 19(2):97-108. PubMed ID: 177778
    [No Abstract]   [Full Text] [Related]  

  • 10. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the serology of Bordetella pertusis. 3. Biological investigations of antigen fractions of ultrasonic extract obtained by column chromatography on DEAE-cellulose (author's transl)].
    Mebel S; Mucke W; Lapaeva IA; Zakharova MS
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(2):241-7. PubMed ID: 4133229
    [No Abstract]   [Full Text] [Related]  

  • 14. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 15. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serologic controls of anti-pertussis vaccination].
    Mynard MC; Aymé G; Triau R
    Rev Immunol Ther Antimicrob; 1969; 33(1):7-20. PubMed ID: 4181401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pertussis].
    Gioannini P
    Minerva Med; 1977 May; 68(24):1605-20. PubMed ID: 194174
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracted protective antigen of Bordetella pertussis. I. Preparation and properties of the solubilized surface of components.
    Helting TB; Blackkolb F
    Acta Pathol Microbiol Scand B; 1981 Apr; 89(2):93-101. PubMed ID: 6266198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.